Clariant AG
Other OTCRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Clariant AG (CLZNY) develops, manufactures, distributes and sells specialty chemicals worldwide, organized into three primary business units: Care Chemicals, which provides industrial and consumer specialties including personal and home care formulations, crop solutions, paints and coatings, aviation, construction chemicals, industrial lubricants, pharmaceutical excipients, oil services and mining solutions; Adsorbents & Additives, encompassing purification, foundry & specialties, cargo & device protection, coatings & adhesives, plastics and e-mobility & electronics additives such as halogen-free flame retardants; and Catalysts, offering products for chemical, fuel, automotive, propylene, syngas & fuels, ethylene, biofuels & derivatives and applied catalyst technologies. Headquartered in Muttenz, Switzerland, and founded in 1995 as a spin-off from Sandoz with roots tracing to 1886, the company operates 71 production sites across Europe, North America, South America, Asia including major facilities in China and India, and other regions, employing 10,465 people as of December 2024 and generating CHF 4.152 billion in sales. Recent developments include the completion of an CHF 80 million expansion of Care Chemicals production at its Daya Bay facility in China in November 2025 to enhance pharmaceutical excipients and specialty chemicals for personal and home care; a CHF 100 million investment finalizing a second production line at Daya Bay in October 2025 for sustainable flame retardants like Exolit OP targeted at e-mobility; and the April 2024 acquisition of Lucas Meyer Cosmetics from IFF for approximately US$810 million to bolster high-value natural cosmetic ingredients, projecting sales growth to USD 180 million by 2028, alongside planned leadership transition in Care Chemicals upon Christian Vang's retirement in 2026.
Clariant AG (CLZNY) Q1 2026 Earnings Call Transcript
Clariant delivers resilient performance in challenging environment
Clariant publishes Integrated Report 2025
Clariant AG (CLZNY) Q4 2025 Earnings Call Transcript
Clariant delivers third year of strong EBITDA margin improvement – EBITDA margin before exceptional items up 180 basis points versus prior year to 17.8 %
Clariant AG (OTCMKTS:CLZNY) Receives Consensus Rating of “Reduce” from Brokerages
Clariant Board of Directors proposes the election of Regula Wallimann and Albert Manifold to the Board
Clariant AG (OTCMKTS:CLZNY) Receives Consensus Recommendation of “Hold” from Brokerages
Clariant announces the divestment of its business in Venezuela
Clariant announces leadership transition in its Business Unit Care Chemicals
Clariant AG (CLZNY) Q3 2025 Earnings Call Transcript
Clariant increases Q3 2025 EBITDA margin before exceptional items by 230 basis points to 17.9 % in continued challenging market environment
Clariant Board of Directors decided to reduce its size and enhance corporate governance
Clariant AG (CLZNF) Q2 2025 Earnings Call Transcript
Clariant delivers strong profitability on flat local currency sales in Q2 2025
Clariant rejects OMV's allegations against four companies related to the 2020 competition law infringement
Clariant rejects Dow Europe's allegations against four companies related to the 2020 competition law infringement
Clariant AG (CLZNF) Q1 2025 Earnings Call Transcript
Clariant delivers further improved profitability in challenging environment – outlook confirmed
Clariant's 30th Annual General Meeting approves all agenda items